Bosh sahifa069620 • KRX
add
Daewoong Pharma
Yopilish kursi
158 800,00 ₩
Kunlik diapazon
154 100,00 ₩ - 159 100,00 ₩
Yillik diapazon
104 000,00 ₩ - 171 600,00 ₩
Bozor kapitalizatsiyasi
1,80 trln KRW
Oʻrtacha hajm
45,30 ming
Narx/foyda
46,49
Dividend daromadliligi
0,39%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 356,49 mlrd | 6,17% |
Joriy xarajat | 144,21 mlrd | 2,17% |
Sof foyda | 21,89 mlrd | 168,81% |
Sof foyda marjasi | 6,14 | 152,67% |
Har bir ulushga tushum | — | — |
EBITDA | 50,94 mlrd | 23,00% |
Amaldagi soliq stavkasi | 20,03% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 102,86 mlrd | -19,04% |
Jami aktivlari | 1,99 trln | 9,98% |
Jami passivlari | 1,06 trln | 20,84% |
Umumiy kapital | 929,54 mlrd | — |
Tarqatilgan aksiyalar | 11,51 mln | — |
Narxi/balansdagi bahosi | 2,27 | — |
Aktivlardan daromad | 4,88% | — |
Kapitaldan daromad | 5,97% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 21,89 mlrd | 168,81% |
Operatsiyalardan naqd pul | 3,08 mlrd | -80,79% |
Sarmoyadan naqd pul | -21,95 mlrd | 62,15% |
Moliyadan naqd pul | 13,82 mlrd | -60,73% |
Naqd pulning sof oʻzgarishi | -5,17 mlrd | 9,92% |
Boʻsh pul | -24,56 mlrd | 41,58% |
Haqida
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Tashkil etilgan
1945
Sayt
Xodimlar soni
1 727
